FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData Read more
FOPE request govt for funding to MSME to upgrade manufacturing facilities for revised Schedule M Read more
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData Read more
Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous NSCLC: GlobalData Read more
India pharma giants and global big pharma join forces for NMEs commercialisation in India: GlobalData Read more